We are advancing novel investigational antiviral agents that have potent activity against difficult to treat or resistant virus strains that threaten human health. Our product candidates are intended to be safe, …

Find the latest Traws Pharma, Inc. (TRAW) stock quote, history, news and other vital information to help you with your stock trading and investing.

Oct 24, 2025 · TRAW | Complete Traws Pharma Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

4 days ago · Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer.

Get the latest Traws Pharma Inc (TRAW) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Dec 5, 2025 · A detailed overview of Traws Pharma, Inc. (TRAW) stock, including real-time price, chart, key statistics, news, and more.

Get Traws Pharma Inc (TRAW:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Dec 2, 2025 · Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases.

Dec 3, 2025 · See the latest Traws Pharma Inc stock price (TRAW:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Jun 30, 2025 · NEWTOWN, Pa., May 15, 2025 (GLOBE NEWSWIRE) — Traws Pharma, Inc. (NASDAQ:TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharmaceutical …